Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients. © 2008 Dove Medical Press Limited. All rights reserved.
CITATION STYLE
Witte, K. K. A., & Clark, A. L. (2008). Carvedilol in the treatment of elderly patients with chronic heart failure. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s1044
Mendeley helps you to discover research relevant for your work.